Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%

A key opinion leader examines the historical context of Demodex blepharitis treatment, discussing the efficacy and limitations of previous therapies, and emphasizes a recently FDA-approved therapy that directly targets Demodex mites, leading to improved efficacy compared to treatments that only address symptoms.